From the Graveyard Shift to the Frontier of Cell Therapy, with Mike Ruane

From the Graveyard Shift to the Frontier of Cell Therapy, with Mike Ruane

From a graveyard shift in a generic drug lab to leading quality for one of the most advanced cell therapy programs on the planet - Mike Ruane's story is one every quality professional needs to hear.

In today's episode I was joined by Mike Ruane, Head of Quality for In Vivo CAR-T at Bristol Myers Squibb.

I really wanted to speak to Mike because his career is one of the more fascinating journeys I have come across in quality leadership. He has spent nearly two decades within what is effectively the same organisation, yet has lived through multiple acquisitions, spin-offs and complete pivots in therapeutic modality - each time emerging in a stronger, more interesting role than before.

Mike began his career at APP Pharmaceuticals on a midnight QC shift, testing in-process samples on a graveyard schedule. From there, he followed the Abraxane asset into aBraxis Bioscience, built out supplier quality relationships across Central and South America, and eventually relocated from Chicago to New Jersey when Celgene consolidated its operations.

That move opened the door to something entirely new - a CAR-T therapy program called BB2121 - a field Mike had never worked in and knew little about. Eight years later, he is now heading quality for in vivo CAR-T, one of the most cutting-edge modalities in all of biopharma.

What makes Mike Ruane such a compelling guest is not just the breadth of his experience but his philosophy. He is a first-principles thinker who has thrived precisely because he never assumed the existing process was the right one. He asks the uncomfortable questions, encourages his team to do the same, and believes deeply that curiosity is the most underrated skill in quality.

We talk about the following:

How working in a lean generic drug environment early in his career shaped his mindset forever

Navigating multiple acquisitions and spin-offs within a single career arc

What it takes to step into an entirely new therapeutic modality with no prior experience

Why curiosity and asking the right questions is the real engine of career growth in quality

How he interviews candidates and what most people get wrong when they are being interviewed

Mike Ruane is a thoughtful, pragmatic quality leader who understands how to balance compliance, collaboration and business reality in complex development environments.

If you are a quality professional working in an early-stage biotech and trying to build the right systems with limited resources, then this episode is for you.

Thank you Mike Ruane for sharing your incredible journey.

Hope everyone enjoys the show.

Timestamps:

(00:00) Introduction to Mike's Career Journey

(02:01) Transitioning Through Acquisitions and Roles

(06:39) Navigating Supplier Quality and External Partnerships

(11:05) The Shift to CAR T Therapy

(16:05) The Importance of Asking Questions

(20:48) Advice for Future Generations

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(78)

My Thoughts on Quality Leadership, Halfway Through Season Four

My Thoughts on Quality Leadership, Halfway Through Season Four

Season Four is at its halfway point, so instead of a guest this week I’ve gone back over the conversations so far and pulled out the theme that came up most often.The quality leader whose main functio...

30 Juli 16min

Speaking the Language of the Business, with Jamey Lindholm

Speaking the Language of the Business, with Jamey Lindholm

Quality culture isn't built by SOPs. It's built in the small moments when a leader reinforces the right behaviour or lets the wrong one slide.Speaking the Language of the Business, with Jamey Lindholm...

21 Juli 38min

The Big Pharma Habits You Have to Unlearn in a Startup, with Dawn Lundin

The Big Pharma Habits You Have to Unlearn in a Startup, with Dawn Lundin

Twenty years at Merck, then a leap into academia and psychedelic medicine - here is how Dawn Lundin built a quality career on instinct.Dawn Lundin on the big pharma habits you have to unlearn in a sta...

14 Juli 29min

How Quality Stopped Being Black and White, with Tim Mitchell

How Quality Stopped Being Black and White, with Tim Mitchell

Forty seven years in quality, and Tim Mitchell says the job he started is nothing like the one he does today.Tim Mitchell on how quality stopped being black and whiteIn today's episode I was joined by...

7 Juli 33min

Swetha Krishnan on her journey from Individual Contributor to Inspiring People Leader

Swetha Krishnan on her journey from Individual Contributor to Inspiring People Leader

She came to the US with her first year's tuition and figured the rest out from there. What followed is one of the most grounded quality leadership journeys I have heard - and one we felt was worth bri...

26 Maj 41min

Building Quality That Scales, with Laura Singer

Building Quality That Scales, with Laura Singer

What does it really take to build a quality organization from the ground up - and do it again, and again, across multiple companies? Laura Singer on building quality that scales.In today's episode I w...

19 Maj 35min

From Virologist to CTO: Leading Quality Through Crisis, with Kimberly Garko

From Virologist to CTO: Leading Quality Through Crisis, with Kimberly Garko

From the lab bench to the C-Suite - and every crisis in between.In today's episode I was joined by Kimberly Garko, former Senior Vice President and Chief Technical Officer at Akebia Therapeutics.I rea...

12 Maj 37min

Three BLAs, Three Journeys, with Irving Ford, Megan Callan, and Jake Treese

Three BLAs, Three Journeys, with Irving Ford, Megan Callan, and Jake Treese

Three BLAs. Three companies. One industry-defining challenge.Jake Trees, Irving Ford, and Megan Callan on What It Really Takes to Cross the Commercial Line in Cell and Gene TherapyIn this special comp...

7 Maj 34min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
dynastin
uppgang-och-fall
rss-borsens-finest
avanzapodden
svd-tech-brief
rss-inga-dumma-fragor-om-pengar
fill-or-kill
tabberaset
borsmorgon
lastbilspodden
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-dagen-med-di
rss-hos-psykologen
borslunch-2
rss-kort-lang-analyspodden-fran-di
rss-veckans-trade
rss-borslunch